Dr. Bhalodia brings over 22 years of clinical expertise and more than a decade of experience as a Principal Investigator, with a specialized focus on Type 2 diabetes, obesity, and GLP-1–relevant metabolic trials. Having led studies for major pharmaceutical organizations, he ensures reliable execution in insulin titration and glucose-lowering therapies. His extensive background managing a large primary care patient panel supports effective recruitment and longitudinal study management.